Compare USA & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | USA | CNMD |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.2B |
| IPO Year | 1994 | 1995 |
| Metric | USA | CNMD |
|---|---|---|
| Price | $5.72 | $36.99 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $48.00 |
| AVG Volume (30 Days) | ★ 1.1M | 402.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $1,374,724,000.00 |
| Revenue This Year | N/A | $0.82 |
| Revenue Next Year | N/A | $5.48 |
| P/E Ratio | ★ N/A | $24.62 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $5.62 | $35.37 |
| 52 Week High | $6.96 | $61.25 |
| Indicator | USA | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.64 | 29.93 |
| Support Level | N/A | $35.37 |
| Resistance Level | $6.63 | $46.08 |
| Average True Range (ATR) | 0.07 | 1.48 |
| MACD | -0.02 | -0.77 |
| Stochastic Oscillator | 26.93 | 10.90 |
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.